1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenue
• 1.4 Market Analysis by Type
• 1.5 Market by Application
  • 1.5.1 Global Next Generation Sequencing (NGS) in Cancer Diagnostic Market Share by Application: 2022 VS 2029
• 1.6 Coronavirus Disease 2019 (Covid-19) Impact: Next Generation Sequencing (NGS) in Cancer Diagnostic Market
  • 1.6.1 How the Covid-19 is Affecting the Next Generation Sequencing (NGS) in Cancer Diagnostic Market
    • 1.6.1.1 Next Generation Sequencing (NGS) in Cancer Diagnostic Market Business Impact Assessment - Covid-19
  • 1.6.2 Market Trends and Next Generation Sequencing (NGS) in Cancer Diagnostic Market Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Next Generation Sequencing (NGS) in Cancer Diagnostic Market Perspective (2016-2029)
• 2.2 Next Generation Sequencing (NGS) in Cancer Diagnostic Market Growth Trends by Regions
  • 2.2.1 Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size by Regions: 2016 VS 2022 VS 2029
  • 2.2.2 Next Generation Sequencing (NGS) in Cancer Diagnostic Market Historic Market Share by Regions (2016-2022)
  • 2.2.3 Next Generation Sequencing (NGS) in Cancer Diagnostic Market Forecasted Market Size by Regions (2022-2029)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porters Five Forces Analysis
  • 2.3.5 Next Generation Sequencing (NGS) in Cancer Diagnostic Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Next Generation Sequencing (NGS) in Cancer Diagnostic Market Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Next Generation Sequencing (NGS) in Cancer Diagnostic Market Players by Market Size
  • 3.1.1 Global Top Next Generation Sequencing (NGS) in Cancer Diagnostic Market Players by Revenue (2016-2022)
  • 3.1.2 Global Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenue Market Share by Players (2016-2022)
  • 3.1.3 Global Next Generation Sequencing (NGS) in Cancer Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Next Generation Sequencing (NGS) in Cancer Diagnostic Market Concentration Ratio
  • 3.2.1 Global Next Generation Sequencing (NGS) in Cancer Diagnostic Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenue in 2019
• 3.3 Next Generation Sequencing (NGS) in Cancer Diagnostic Market Key Players Head office and Area Served
• 3.4 Key Players Next Generation Sequencing (NGS) in Cancer Diagnostic Market Product Solution and Service
• 3.5 Date of entering into Next Generation Sequencing (NGS) in Cancer Diagnostic Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2029)

• 4.1 Global Next Generation Sequencing (NGS) in Cancer Diagnostic Market Historic Market Size by Type (2016-2022)
• 4.2 Global Next Generation Sequencing (NGS) in Cancer Diagnostic Market Forecasted Market Size by Type (2022-2029)

5 Next Generation Sequencing (NGS) in Cancer Diagnostic Market Breakdown Data by Application (2016-2029)

• 5.1 Global Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size by Application (2016-2022)
• 5.2 Global Next Generation Sequencing (NGS) in Cancer Diagnostic Market Forecasted Market Size by Application (2022-2029)

6 North America

• 6.1 North America Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size (2016-2022)
• 6.2 Next Generation Sequencing (NGS) in Cancer Diagnostic Market Key Players in North America (2019-2022)
• 6.3 North America Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size by Type (2016-2022)
• 6.4 North America Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size by Application (2016-2022)

7 Europe

• 7.1 Europe Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size (2016-2022)
• 7.2 Next Generation Sequencing (NGS) in Cancer Diagnostic Market Key Players in Europe (2019-2022)
• 7.3 Europe Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size by Type (2016-2022)
• 7.4 Europe Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size by Application (2016-2022)

8 China

• 8.1 China Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size (2016-2022)
• 8.2 Next Generation Sequencing (NGS) in Cancer Diagnostic Market Key Players in China (2019-2022)
• 8.3 China Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size by Type (2016-2022)
• 8.4 China Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size by Application (2016-2022)

9 Japan

• 9.1 Japan Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size (2016-2022)
• 9.2 Next Generation Sequencing (NGS) in Cancer Diagnostic Market Key Players in Japan (2019-2022)
• 9.3 Japan Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size by Type (2016-2022)
• 9.4 Japan Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size by Application (2016-2022)

10 Southeast Asia

• 10.1 Southeast Asia Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size (2016-2022)
• 10.2 Next Generation Sequencing (NGS) in Cancer Diagnostic Market Key Players in Southeast Asia (2019-2022)
• 10.3 Southeast Asia Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size by Type (2016-2022)
• 10.4 Southeast Asia Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size by Application (2016-2022)

11 India

• 11.1 India Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size (2016-2022)
• 11.2 Next Generation Sequencing (NGS) in Cancer Diagnostic Market Key Players in India (2019-2022)
• 11.3 India Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size by Type (2016-2022)
• 11.4 India Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size by Application (2016-2022)

12 Central & South America

• 12.1 Central & South America Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size (2016-2022)
• 12.2 Next Generation Sequencing (NGS) in Cancer Diagnostic Market Key Players in Central & South America (2019-2022)
• 12.3 Central & South America Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size by Type (2016-2022)
• 12.4 Central & South America Next Generation Sequencing (NGS) in Cancer Diagnostic Market Size by Application (2016-2022)

13 Key Players Profiles

• 13.1 Company Details
• 13.2 Business Overview and Its Total Revenue
• 13.3 Next Generation Sequencing (NGS) in Cancer Diagnostic Market Introduction
• 13.4 Next Generation Sequencing (NGS) in Cancer Diagnostic Market Business (2016-2022)
• 13.5 Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

Global Next Generation Sequencing (NGS) in Cancer Diagnostic Market Research Report 2022-2028
The Global Next Generation Sequencing (NGS) in Cancer Diagnostic Market 2022 Research Report is a professional and in-depth study on the current state of the Next Generation Sequencing (NGS) in Cancer Diagnostic Market industry. This report provides detailed information on the Next Generation Sequencing (NGS) in Cancer Diagnostic market, based on logical and insightful information.

The regional description analyzes and forecasts the Next Generation Sequencing (NGS) in Cancer Diagnostic market at the global levels, covering the key regions for growth. The Next Generation Sequencing (NGS) in Cancer Diagnostic Market Report analyzes the scope for growth in the market in different regions. The report covers the regions of North America, Latin America, Asia-Pacific, Europe, the Middle East and Africa. The report additionally covers the key areas for growth present in these regional markets, where the companies entering the Next Generation Sequencing (NGS) in Cancer Diagnostic market must focus for growth.

The report in contrast to the analysis of the key players, provides insights into the competitive landscape of the Next Generation Sequencing (NGS) in Cancer Diagnostic market, along with analyzing the investment opportunities for the market participants and entrants.

Next Generation Sequencing (NGS) in Cancer Diagnostic market report analyzes what are the factors that are driving the growth of the Next Generation Sequencing (NGS) in Cancer Diagnostic market and the factors that are restricting the growth. The report deeply analyzes the volume trends, value of the market, pricing history, etc. which would help the companies entering the Next Generation Sequencing (NGS) in Cancer Diagnostic market to understand the growth opportunities and threats that are present in the market. A number of opportunities for investment in the Next Generation Sequencing (NGS) in Cancer Diagnostic market are discovered by analysts and are discussed in this report.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product specification, price, cost, revenue and contact information.

KEY PLAYERS engaged in the Next Generation Sequencing (NGS) in Cancer Diagnostic market include
Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies Inc. (U.S.), Myriad Genetics Inc. (U.S.), BGI (China), Perkin Elmer Inc. (U.S.), Foundation Medicine Inc. (U.S.), PacBio (U.S.), Oxford Nanopore Technologies plc. (U.K.), Paradigm Diagnostics Inc. (U.S.), Caris Life Sciences (Japan), Partek, Incorporated (U.S.), Eurofins Scientific (Luxembourg), Qiagen (Germany)

The report firstly introduced the Next Generation Sequencing (NGS) in Cancer Diagnostic market basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The report includes six parts, dealing with:
1) Basic information
2) The Asia Next Generation Sequencing (NGS) in Cancer Diagnostic market.
3) The North American Next Generation Sequencing (NGS) in Cancer Diagnostic industry.
4) The European Next Generation Sequencing (NGS) in Cancer Diagnostic industry.
5) Market entry and investment feasibility.
6) The report conclusion.